These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96. Correction to: Novel method to estimate the appropriate dosing interval for activated charcoal to avoid interaction with other drugs. Ohtani H; Nakamura K; Imaoka A; Akiyoshi T Eur J Clin Pharmacol; 2020 Nov; 76(11):1537. PubMed ID: 32936338 [TBL] [Abstract][Full Text] [Related]
97. Activated charcoal--past, present and future. Derlet RW; Albertson TE West J Med; 1986 Oct; 145(4):493-6. PubMed ID: 3538661 [TBL] [Abstract][Full Text] [Related]
98. Clinical features and management of poisoning due to antimalarial drugs. Jaeger A; Sauder P; Kopferschmitt J; Flesch F Med Toxicol Adverse Drug Exp; 1987; 2(4):242-73. PubMed ID: 3306266 [TBL] [Abstract][Full Text] [Related]
99. Oral activated charcoal in the treatment of intoxications. Role of single and repeated doses. Neuvonen PJ; Olkkola KT Med Toxicol Adverse Drug Exp; 1988; 3(1):33-58. PubMed ID: 3285126 [TBL] [Abstract][Full Text] [Related]
100. Management of dapsone poisoning complicated by methaemoglobinaemia. Dawson AH; Whyte IM Med Toxicol Adverse Drug Exp; 1989; 4(5):387-92. PubMed ID: 2811676 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]